Clinical Trials Directory

Trials / Completed

CompletedNCT03007108

Age-dependency of Thrombin Generation Using a New Standardized Assay

Determination of Normal Range Values of Thrombin Generation Parameters in Pediatrics Population Using a New Standardized Thrombin Generation Assay

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
270 (actual)
Sponsor
CHU de Reims · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The aim of this study is to establish normal values of thrombin generation assay parameters in pediatrics, according to different age groups. The standardized thrombin generation assay "Genesia™" will be used. Different age groups of healthy children will be recruited : neonates, 1-3 months, 3-6 months, 6-12 months, 1-2 years, 2-6 years, 6-12 years, and 12-15 years old. Adults values will be obtained (healthy adults \> 18 years old).

Detailed description

Materials and Methods Collection of blood samples Blood samples of 240 healthy children will be obtained from the blood that will be collected for the routine coagulation screening (in neonates and in children \< 18 months) or at the time of surgery in children aged \> 18 months. Healthy neonates will be recruited by the neonatologists. Children aged from 1 month to 15 years will be included by anesthesiologists before minor elective surgery such as tonsillectomy, adenoidectomy, phimosis or oral surgery. Additionally, blood from adults referred for thrombophilia testing will be studied. This study was approved by French authorities (ANSM and CPP). Inform consent will be obtained from all participants. Blood will be collected into plastic tubes containing sodium citrate (0.106 M, tubes from "Starstedt"). Platelet poor plasma will be obtained by two centrifugations for 10 minutes at 2500 g at room temperature and stored at - 70°C until further examination. Statistical analysis Statistical analysis will be performed as 1) a descriptive analysis (frequency and percentage for qualitative data, mean, SD and centiles for quantitative data), and 2) a comparison analysis (student, Mann-Withney, Kruskall- Wallis).

Conditions

Interventions

TypeNameDescription
OTHERblood withdrawal

Timeline

Start date
2017-01-10
Primary completion
2018-01-01
Completion
2018-01-01
First posted
2017-01-02
Last updated
2018-02-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03007108. Inclusion in this directory is not an endorsement.